openPR Logo
Press release

Liver Fibrosis Drug Market Therapeutic Survey Reviews, Analysis 2019

05-05-2020 10:04 PM CET | Health & Medicine

Press release from: Market Insighs Reports

The report titled "Liver Fibrosis Drug Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.

The global Liver Fibrosis Drug market is valued at 14300 million US$ in 2018 and will reach 12640 million US$ by the end of 2025, growing at a CAGR of -1.7% during 2019-2025.

Liver fibrosis is the scarring process that represents the livers response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.

The classification of Liver Fibrosis Drug includes nucleoside, interferon and others, and the proportion of nucleoside type in 2018 is about 45.37%, and the proportion keeps stable trend from 2014 to 2025.Liver fibrosis drug is widely used for Hepatitis, Liver Fibrosis and Other. The most proportion of Interferon is used for hepatitis, and the proportion in 2018 is 68.37%.

Available discount (Exclusive Offer Flat 30%)

Click the link to get a Sample Copy of the Report before purchase:

https://www.marketinsightsreports.com/reports/06061278280/global-liver-fibrosis-drug-market-insights-forecast-to-2025/inquiry?Source=Openpr&Mode=47

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Liver Fibrosis Drug Market: Gilead, Biogen Idec, Merck KGaA, Bristol-Myers Squibb Company, Roche, Merck & Co., Tri-Prime and others.

News Update:

Basel, 03 May 2020 (Roche)

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA)1 for its new Elecsys? Anti-SARS-CoV-2 antibody test. The test is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2. Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month to serve healthcare systems in countries accepting the CE mark2 as well as the U.S.

May 01, 2020 (Gilead)

OSTER CITY, Calif.--(BUSINESS WIRE)--May 1, 2020-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at additional hospitals across the country. Allocation of the currently limited available supply of remdesivir will be made based on guiding principles that aim to maximize access for appropriate patients in urgent need of treatment, with direction from and in collaboration with the government.

Global Liver Fibrosis Drug Market Split By Product Type and Applications:

This report segments the global Liver Fibrosis Drug Market on the basis of Types are:
Nucleoside
Interferon
Other

On the basis of Application, the Global Liver Fibrosis Drug Market is segmented into:
Hepatitis
Liver Fibrosis
Other

Inquire for Discount:

https://www.marketinsightsreports.com/reports/06061278280/global-liver-fibrosis-drug-market-insights-forecast-to-2025/discount?Source=Openpr&Mode=47

Regional Analysis For Liver Fibrosis Drug Market:

For the comprehensive understanding of market dynamics, the global Liver Fibrosis Drug Market is analysed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analysed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

Important Features that are under Offering and Key Highlights of the Reports:

- Detailed overview of Liver Fibrosis Drug Market.
- Changing market dynamics of the Liver Fibrosis Drug Market industry.
- In-depth segmentation of Liver Fibrosis Drug Market by Type, Application etc.
- Historical, current and projected market size in terms of volume and value.
- Recent industry trends and developments.
- Competitive landscape of Liver Fibrosis Drug Market.
- Strategies of key players and product offerings.
- Potential and niche segments/regions exhibiting promising growth.

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/06061278280/global-liver-fibrosis-drug-market-insights-forecast-to-2025?Source=Openpr&Mode=47

We also offer customization on reports based on specific client requirement:

1- Country level analysis for any 5 countries of your choice.
2- Competitive analysis of any 5 key market players.
3- 40 analyst hours to cover any other data points

Reference and Source:

https://www.roche.com/media/releases/med-cor-2020-05-03.htm

https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19

Related Report:

France Uterine Fibroid Embolization (UFE) Procedures

https://www.marketinsightsreports.com/reports/03293102/france-uterine-fibroid-embolization-ufe-procedures-outlook-to-2023

Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States

+Contact US :

Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare,
Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.
MarketInsightsReports provides global and Chinese and regional market intelligence coverage,
a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liver Fibrosis Drug Market Therapeutic Survey Reviews, Analysis 2019 here

News-ID: 2035243 • Views: 304

More Releases from Market Insighs Reports

Malaysia Freight & Logistics Market Report 2020 by Key Players, Types, Applicati …
The report presents an in-depth assessment of the Malaysia Freight & Logistics including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Malaysia Freight & Logistics investments from 2020 till 2023. The Malaysian freight & logistics market was estimated to be worth USD 53.45 billion in 2017. The Malaysian freight forwarding
Dynamic Wireless EV Charging System Market Precise Outlook 2020-WiTricity Corpor …
The Global Dynamic Wireless EV Charging System Market Research Report Forecast 2020 - 2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Dynamic Wireless EV Charging System market and offers a clear
Automotive NOx Sensors Market 2020 Technology Advancement and Future Scope - Con …
The report titled "Automotive NOx Sensors Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts. The Automotive NOx Sensors
Medical Device Cleaning Industry Analysis With Vital Players Profiles, Forecast …
This report describes the key players in the Medical Device Cleaning industry, their market shares, product portfolios and company profiles. Key market players are analyzed based on output, gross margin, market value, and price structure. Competitive market scenarios between Medical Device Cleaning players help industry aspirants plan strategies.?The statistics provided in this report will be an accurate and useful guide to shaping business growth. Get Sample Copy of this Report: https://www.marketinsightsreports.com/reports/04071968605/global-medical-device-cleaning-market-research-report-2020/inquiry?Mode=52 Global Medical

All 5 Releases


More Releases for Liver

Global Liver Detox Market Research Report
This report studies the global Liver Detox market status and forecast, categorizes the global Liver Detox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Health Plus(UK) Swisse(AU) ReNew Life Formulas, Inc.(US) NATURE' S BOUNTY(US) Healthy Care(AU) Evolution Slimming Ltd(UK) PureFormulas Inc.
Liver Cirrhosis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Cirrhosis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and
Liver Transplant Rejection - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Transplant Rejection - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection - Pipeline Review, H1 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape. Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability
Global Liver Disease Treatment Market
The Liver Disease Treatment Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The liver is one of the most important organs of the human body and performs major functions, such as removal of harmful substances from blood, maintains adequate level of chemicals
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production
Liver Disease Diagnostics by Immunoblot Test System
Mainz based ORGENTEC Diagnostika GmbH has developed a new immunoblot test for the serological diagnosis of autoimmune liver disease. Liver-9-Line facilitates the rapid and cost-effective diagnosis of autoimmune hepatitis (type 1 and type 2 AIH) and primary biliary cirrhosis (PBC) in a single step. The test system also allows for the reliable differentiation of these autoimmune diseases from other diseases of the liver. This immunoblot is suitable for initial and differential